UPC
Universe Pharmaceuticals Inc
NASDAQ: UPC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.49
-3.25% today
Updated 2026-10-30
Market cap
$14.47M
P/E ratio
—
P/S ratio
0.82x
EPS (TTM)
$-1.38
Dividend yield
—
52W range
$2 – $18
Volume
0.2M
Universe Pharmaceuticals Inc (UPC) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-11900.0%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-06-30 | $0.00 | $-9.44 | — | — | — |
| 2025-03-31 | $0.00 | $0.00 | — | $9.15M | — |
| 2024-06-30 | $0.00 | $0.00 | — | $12.88M | — |
| 2022-12-31 | $0.00 | $-0.48 | — | $15.94M | -32.7% |
| 2022-06-30 | $0.00 | $0.08 | — | $24.20M | — |
| 2021-12-31 | $0.00 | $0.60 | — | $23.69M | — |
| 2021-06-30 | $0.00 | $0.44 | — | — | — |
| 2020-12-31 | $0.00 | $0.36 | — | — | — |
| 2020-09-30 | $0.00 | $0.22 | — | — | — |
| 2020-06-30 | $0.00 | $0.36 | — | — | — |
| 2020-03-31 | $0.00 | $0.08 | — | — | — |
| 2019-12-31 | $0.00 | $0.16 | — | — | — |
| 2019-09-30 | $0.00 | $0.16 | — | — | — |
Frequently asked questions
Has Universe Pharmaceuticals Inc beaten earnings estimates?
Universe Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.